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      A number of 6-hydroxy-2-benzylidene-3-coumaranones were synthesized from condensation of 6-
hydroxy-3-coumaranone with appropriate aldehydes and were evaluated for their antioxidant activities. The 
antioxidant activity was assessed using two methods, including, 1,1-biphenyl-2-picrylhydrazyl (DPPH) 
radical scavenging, and reducing power assays. Some of the benzylidene coumaranones showed antioxidant 
activity more than Trolox as reference antioxidant. 
 




     Free radicals are produced in the normal or 
pathological cell metabolism. Oxidation is one 
of the essential processes to many living 
organisms to produce energy for biological 
processes [1]. On the other hand, generation and 
uncontrolled production of reactive oxygen 
species (ROS) and free radicals is involved in 
the onset of many diseases such as cancer, 
rheumatoid arthritis, cirrhosis, arteriosclerosis 
inflammation, ischemic heart disease, 
neurodegenerative such as Alzheimer and 
Parkinson diseases [2]. There are many kind of 
(ROS) in human body including superoxide 
anion, hydrogen peroxide, hydroxyl radical, and 
by-product of a variety of aerobic metabolism. 
The human body possesses innate defense 
mechanism in the form of enzymes such as 
glutathione peoxidase, superoxide dismulate 
and catalase [3-4]. In many latest studies has 
reported that antioxidant compounds in foods 
play an important role as a health-protecting 
factor. Scientific evidence suggested that 
antioxidants reduce the risk of chronic diseases 
including cancer, and heart diseases [5]. 
Primary source of naturally occurring 
antioxidants are grains, fruits, and vegetables. 
Plant sourced food antioxidant such as vitamin 
C, vitamin E, carotenes, and other carotenoids 
have been used as a supplementary antioxidant. 
Apart from these, polyphenolic plant secondary 
metabolites such as flavonoids play an 
important role in the defense against free 
radicals. These compounds also show 
antibacterial, antiviral, anti-inflammatory, 
antiatherogenic properties, and preventing role 
in cancer, Alzheimer’s, Parkinson’s and 
cardiovascular diseases. Some of these activities 
are at least partially related to their antioxidant 
properties [5-6]. Aurones are very similar to 
flavonoids in structure and a series of aurone 
derivatives have been used for in vivo 
imagining of β-amyloid plaques in the brain of 
Alzheimer’s disease [7]. 
Recently, silica sulfuric acid (SSA) has been 
introduced as a novel solid inorganic acidic 
proton source catalyst by the reaction of silica 
gel and chlorosulfonic acid for the various 
 
 
functional group transformations [8-10].
 
In 
continuation of our studies in this regards[9], 
we report our efforts towards a new 
heterogeneous procedure for the synthesis of 6-
hydroxy-2-benzylidene-3-coumaranones and 
evaluate their in vitro antioxidant activities 
(Figure1). In this project we used solid silica 
sulfuric acid (SSA) as a heterogeneous catalyst 
for the synthesis of 6-hydroxy-3-coumaranone 
from resorcinol and bromoacetyl bromide. 
Remarkable point about this reaction is that it is 
easy, clean and without any work-up procedure 
because hydrogen bromide gas is evolved from 
the reaction vessel immediately. This catalyst 
has no solubility in general solvents, so it is 
recovered by a simple filtration after ending the 
reaction. 
 
MATERIALS AND METHODS 
General 
      All chemicals were purchased from Merck 
and Fluka chemical companies. Column 
chromatography was performed using silica gel 
60 (230-400 mesh). All yields refer to isolated 
yield. The structure of compounds was 
characterized by IR, 
1
H NMR, and 
13
C NMR 
spectra. The melting point was taken on a 
Kofler hot stage apparatus and is uncorrected. 
IR spectrum was recorded on a Shimadzu 470 
spectrophotometer (KBr disk). 
1
H NMR 
spectrum was recorded on a Bruker FT-300 
NMR spectrophotometer using DMSO-d6 as 
solvent and TMS as an internal standard. The 
purity of the compound was monitored by thin 
layer chromatography. 
General procedure for synthesis of 6-hydroxy-3-
coumaranone 
The starting 6-hydroxy-3-coumaranone 4 (see 
Figure1) was prepared by dissolving resorcinol 
(1 mmol) and bromoacetyl bromide (1 mmol) in 
acetonitrile (3 ml) with 400 mg silica sulfuric 
acid added as catalyst. The reaction mixture was 
heated at 80 
o
C for 3 h. After cooling to room 
temperature and filtering the reaction mixture, 
the compound 3 was purified by column 
chromatography. Subsequently, the compound 3 
was cyclized using NaOH 2 M to produce 6-
hydroxy-3-coumaranone 4 in 75% yield after 1 




H NMR (DMSO-d6): δ 
7.41 (d, J = 8.5 Hz, 1H), 6.54-6.56 (d, J = 8.5 
Hz, 1H), 6.66 (s, 1H), 4.60 (s, 2H), 4.58 (s, 1H) 
ppm; IR (KBr, cm
-1
): υ 1745 (C=O), 3452 (OH). 
General procedure for synthesis of 6-hydroxy-2-
benzylidene-3-coumaranone 
To a solution of compound 4 (1 mmol), and 
appropriate aryl aldehyde (1 mmol) in ethanol 
(3 ml) was added piperazine (0.1 mmol) as the 
basic catalyst. The reaction mixture was heated 
in 80 
o
C for 2-3 h. The reaction mixture was 
allowed to stand at room temperature for 24 h. 
The precipitate was filtered, dried, and 
crystallized from acetic acid to afford pure 6-
hydroxy-2-benzylidene-3-coumaranones 5a-e 
(Table 1). Structural assignments of the 














NMR (DMSO-d6, 300 MHz): δ 6.68 (dd, J1 = 
1.8 Hz, J2 = 10 Hz, H5), 6.70 (s, overlap, =CH), 
6.78 (d, J = 1.8 Hz, H7), 6.88 (d, J = 8.7 Hz, 
2H), 7.60 (d, J = 8.4 Hz, H4), 7.81 (d, J = 8.7 
Hz, 2H) ppm; 
13
C NMR (DMSO-d6, 75 MHz): δ 
99.7, 113.5, 114.1, 114.9, 117.2, 124.9, 126.9, 
134.7, 147.6, 160.7, 167.9, 169.5, 183.8 ppm; 
IR (KBr, cm
-1
): υ 1740 (C=O), 3445 (OH). 
2-(2',4'-dihydroxybenzylidene)-6-hydroxy-3-
coumaranone (5b) 





(DMSO-d6, 300 MHz): δ 7.96-7.90 (m, 2H, H6’, 
H4), 7.35 (s, 1H, =CH), 6.70 (s, 1H, H7), 6.55 
(d, J = 8.7 Hz, 1H, H5), 6.25 (d, J = 8.7 Hz, 1H, 
H5), 6.15 (s, 1H, H3), 3.49-3.42  (s, 3H, OH) 
ppm; 
13
C NMR (DMSO-d6, 75 MHz): δ 182.1, 
167.0, 165.2, 159.3, 157.3, 146.7, 131.3, 128.3, 
115.2, 112.3, 108.3, 105.7, 103.5 ppm; IR (KBr, 
cm
-1
): υ 1735 (C=O), 3455 (OH). 
2-(2',5'-dihydroxybenzylidene)-6-hydroxy-3-
coumaranone (5c) 





(DMSO-d6, 300 MHz): δ 7.59 (d, J = 8.5 Hz, 
1H, H3
‚
), 7.51 (d, J = 8.5 Hz, 1H, H4
‚
), 7.46 (s, 
1H, H6
‚
), 7.11 )d, J = 8.7 Hz, 1H, H4), 7.10 (s, 
1H, H7), 6.95 (d, J = 8.7 Hz, 1H, H5), 6.75 (s, 
1H, =CH), 3.38-3.42 (s, 3H, OH) ppm; 
13
C 
NMR (DMSO-d6, 75 MHz): δ 182.2, 167.1, 
165.0, 151.2, 149.5, 147.0, 128.4, 117.5, 116.5, 
113.2, 103.4, 101.2 ppm; IR (KBr, cm
-1
): υ 
1750 (C=O), 3115 (OH). 
2-(2'-hydroxy-3'-methoxybenzylidene)-6-
hydroxy-3-coumaranone (5d) 





(DMSO-d6, 300 MHz): δ 7.71 (d, J = 8.7 Hz, 
1H, H4), 7.62 (s, 1H, =CH), 7.11-7.17 (m, 2H, 
H5’, H6’), 7.04  (s, 1H, H7), 6.91 (s, 1H, H7), 
6.73 (d, J = 8.8 Hz, 1H, H4), 6.50 (d, J = 8.8 Hz, 






C NMR (DMSO-d6, 75 MHz): δ 182.1, 
167.5, 165.2, 151.2, 148.4, 146.7, 128.0, 122.6, 
121.4, 117.4, 115.2, 111.8, 105.3, 101.3, 56.4 
ppm; IR (KBr, cm
-1









(DMSO-d6, 300 MHz): δ 7.61 (d, J = 8.7 Hz, 
1H, H5
‚
), 7.49 (d, J = 8.7 Hz, 1H, H6
‚
), 7.53 (s, 
1H, H2
‚
), 6.91 )d, J = 8.8 Hz, 1H, H4), 6.80 (s, 
1H, H7), 6.71 (d, J = 8.7 Hz, 1H, H5), 6.80 (s, 
1H, =CH), 3.85 (s, 3H, OCH3), 3.80 (s, 2H, 
OH) ppm; 
13
C NMR (DMSO-d6, 75 MHz): δ 
182.3, 167.5, 165.1, 149.2, 147.4, 146.7, 128.1, 
125.6, 121.5, 116.4, 115.3, 111.6, 101.2, 56.2 
ppm; IR (KBr, cm
-1
): υ 1743 (C=O), 3250 (OH). 
 
Table 1. Antioxidant activities of 2-benzylidene-3-coumaranones in comparison to Trolox 
Entry Compound DPPH radical scavenging 











































































































































































7 Trolox 36.27 42 
 
Figure 1. Synthetic route for 6-hydroxy-2-benzylidene-3-coumaranones. 
 
Antioxidant assays 
DPPH radical scavenging assay 
The compounds were dissolved in appropriate 
solvent mixed with 1 mL of 0.2 mM 2,2-
diphenyl-1-picrylhydrazyl radical (DPPH) in 
ethanol, and final volume was adjusted to 2 mL. 
Mixtures were variously shaken and left for 30 
min in the dark. Absorbance was measured at 
517 nm using a UV–VIS spectrophotometer. 1 
mL of 0.2 mM DPPH diluted in 1 mL of ethanol 
was used as control. Neutralization of DPPH 
radical was calculated using the equation: S (%) 
= 100 (Ao-As)/Ao, where Ao is the absorbance of 
the control (containing all reagents except the 
test compound) and As is the absorbance of the 
test sample. Results were compared to activity of 
Trolox. The IC50 values represented the 
concentration of the test compounds that caused 
50% inhibition are shown in Table 1. 
Ferric reducing antioxidant power (FRAP) assay 
The FRAP assay reagent was prepared by adding 
10 vol of 30 mM acetate buffer, pH 3.6 (1 g 
sodium acetate and 16 mL glacial acetic acid), 1 
vol of 10 mM 2,4,6-tripyridyl-triazine prepared 
in 40 mM HCl and 1 vol of 20 mM FeCl3. The 
mixture was diluted to 1/3 with methanol and 
pre-warmed at 37 
o
 C. This reagent (3 mL) was 
mixed with 0.1 mL diluted the test compounds. 
The mixture was shaken and incubated at 37 
o
 C 
for 8 min and the absorbance was read at 593 
nm. A blank with only 0.1 mL methanol was 
used for calibration. The difference in 
absorbance between the tested sample and the 
blank reading was calculated and the data were 
expressed as mM of ferric reduced to ferrous 
form (Table 1). 
RESULTS AND DISCUSSION 
Chemistry 
The synthesis of final compounds begins by 
reaction of resorcinol with bromoacetyl bromide 
using SSA as the heterogeneous catalyst. The 
first intermediate product was then cyclized 
using NaOH 2 M to give 6-hydroxy-3-
coumaranone 3 in 75% yield. In the next stage, 
condensation of 6-hydroxy-3-coumaranone 3 
with different aryl aldehydes in basic condition 
and EtOH as the solvent afforded 6-hydroxy-3-
croumanone derivatives 5a-e in 60-80% yields. 
Antioxidant activity 
The antioxidant activity was assessed using two 
methods, including, 1,1-biphenyl-2-
picrylhydrazyl (DPPH) radical scavenging [11], 
and ferric reducing antioxidant power [12] 




the literature (Table 1). The DPPH is a stable 
free radical with maximal absorption at 517 nm. 
It loses this absorption when reduced by an 
antioxidant or a free radical species. The 
decrease in absorbance at a reaction time is used 
in determining the antioxidant activity of the 
tested substances with Trolox (2,5,7,8-
tetramethychroman-2-carboxylic acid) as the 
standard. In FRAP assay, Fe
3+
, can be reduced 
by the antioxidant to a catalytically ion Fe
2+
 that 
provokes the antioxidant to behave as 
prooxidant. The FRAP assay measure the ability 
of a compound to reduce the 2,4,6-tripyridyl-s-
triazine complex. FRAP values are obtained by 
comparing the absorbance change at 593 nm in 
test reaction mixtures with those containing 
ferrous ions in known concentration. FRAP 
values of coumaranones is shown in Table 1 
The results of antioxidant activity in both 
methods are approximately similar to each 
other. All the synthesized compounds except 4, 
5a, exhibited very good antioxidant properties 
according to DPPH method. They were also 
more potent than Trolox as reference 
compound. It should be noted that when 
electron-donating groups such as hydroxyl and 
methoxy are added to the phenyl ring derived 
from aldehyde, the antioxidant activity is 
increased. This is due to the stabilization of the 
generated radical during oxidation. The 
compounds 5b, 5c, 5d, 5e have well 
antioxidative activity with a major activity for 
5b (IC50 23.99 µM).
  
The results of antioxidant activity indicated that 
in addition to phenyl moiety, benzofuranone 
ring was also effective and necessary in the 
assays. However, it is seems that benzofuranone 
moiety delocalized free electron during 
oxidation. For example, compound showed 
antioxidative activity having IC50 values higher 
than 100 µM respectively via DPPH method, 
whereas benzylidene coumaranone similarities 
(5a, 5b, 5c, 5d, 5d, 5e) have IC50 values 50.22, 
23.99, 27.53, 24.71, 26.47 µM respectively via 
the same assay. Overall, the result of DPPH 
assay was relatively consistent with that of 
reducing power assay. The potencies for the 
antioxidative activity of the test compounds 
compared to the reference drug are in the 
following order: 5b > 5d > 5e > 5c >  Trolox > 
5a > 4. 
 
CONCLUSION 
    In summary, we have reported biological 
evaluation of benzylidene coumaranones, which 
represent antioxidant activity. Also, we 
developed a new methodology for the synthesis 
of 6-hydroxy-3-coumaranone under 
heterogeneous condition by silica sulfuric acid. 
Some of the synthesized benzylidene 
coumaranones showed antioxidant activity more 
potent that the reference drug. 
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